* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
XKLS:7178'
s PEG Ratio Range Over the Past 10 Years
Min: 0.67 Med: 1.27 Max: 10.79
Current: 1.96
During the past 13 years, Y.S.P. Southeast Asia Holding Bhd's highest PEG Ratio was 10.79. The lowest was 0.67. And the median was 1.27.
XKLS:7178's PEG Ratio is ranked worse than 54.29% of 350
companies
in the Drug Manufacturers industry
Industry Median: 1.685
vs XKLS:7178: 1.96
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Y.S.P. Southeast Asia Holding Bhd PEG Ratio Related Terms
Y.S.P. Southeast Asia Holding Bhd PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7178 vs ZTS, UTHR, VTRS: PEG Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Y.S.P. Southeast Asia Holding Bhd PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a PEG Ratio of 1.96 as of Jul. 11, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. This is 54% above median its historical median of 1.27. Over the past decade, Y.S.P. Southeast Asia Holding Bhd's PEG Ratio has ranged from 0.67 to 10.79. According to the industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #190 out of 350 companies in the Drug Manufacturers industry, placing it in the top 54.3%.
Is Y.S.P. Southeast Asia Holding Bhd's PEG Ratio too high?
Y.S.P. Southeast Asia Holding Bhd's current PEG Ratio of 1.96 is 54% above median its 10-year median of 1.27. Over the past 10 years, this metric has ranged from a low of 0.67 to a high of 10.79. The Drug Manufacturers industry median PEG Ratio is 1.69. Y.S.P. Southeast Asia Holding Bhd's value of 1.96 is 16.3% above this industry median. Based on the distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #190 out of 350 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #190 out of 350 companies for PEG Ratio. This places Y.S.P. Southeast Asia Holding Bhd in the lower half of its industry. The industry median PEG Ratio is 1.69. Y.S.P. Southeast Asia Holding Bhd's value of 1.96 is 16.3% above this benchmark. Historically, Y.S.P. Southeast Asia Holding Bhd's own PEG Ratio has ranged from 0.67 to 10.79 over the past decade. While the company's 10-year median is 1.27 vs. the industry median of 1.69, Y.S.P. Southeast Asia Holding Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.69, based on 350 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Y.S.P. Southeast Asia Holding Bhd's current PEG Ratio of 1.96 is 16.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Y.S.P. Southeast Asia Holding Bhd and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current PEG Ratio is 1.96, which is 54% above median its own 10-year median of 1.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.41, compared to a current price of RM2.02 — trading 16.2% below its estimated fair value. The current PEG Ratio is 1.96, which is 54% above median its 10-year median of 1.27 and 16.3% above the Drug Manufacturers industry median of 1.69. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current PEG Ratio is 1.96 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued.
The current stock price of RM2.02 is trading 16.2% below its estimated GF Value™ of RM2.41.
GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7178:
PEG Ratio: 1.96 (54% above median its 10-year median of 1.27)
GF Value™: RM2.41 vs. price of RM2.02 (16.2% below fair value)
Industry Position: 16.3% above the Drug Manufacturers median (#190 of 350)
No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Y.S.P. Southeast Asia Holding Bhd Business Description
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
80GF Score
Get the complete analysis for XKLS:7178
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7178 has been successfully added to your 
